Targeting the C3a–C3aR and C5a–C5aR1 pathways and their influence on adhesion molecule-mediated immune cell infiltration holds significant promise for mitigating inflammation and potentially halting or slowing the progression of organ damage in Fabry disease. The gene discussed is C3AR1; the disease is Fabry disease.